Copyright Reports & Markets. All rights reserved.

Global Oral Solid Dosage Pharmaceutical Formulation Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Oral Solid Dosage Pharmaceutical Formulation Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Product
      • 1.4.2 Capsules
      • 1.4.3 Tablets
      • 1.4.4 Others
    • 1.5 Market by End User
      • 1.5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Drugstores
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size
      • 2.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue 2014-2025
      • 2.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales 2014-2025
    • 2.2 Oral Solid Dosage Pharmaceutical Formulation Growth Rate by Regions
      • 2.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Regions
      • 2.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers
      • 3.1.1 Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturers
      • 3.1.2 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Manufacturers
      • 3.1.3 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers
      • 3.2.1 Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Manufacturers (2014-2019)
    • 3.3 Oral Solid Dosage Pharmaceutical Formulation Price by Manufacturers
    • 3.4 Oral Solid Dosage Pharmaceutical Formulation Manufacturing Base Distribution, Product Types
      • 3.4.1 Oral Solid Dosage Pharmaceutical Formulation Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Oral Solid Dosage Pharmaceutical Formulation Product Type
      • 3.4.3 Date of International Manufacturers Enter into Oral Solid Dosage Pharmaceutical Formulation Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales by Product
    • 4.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Product
    • 4.3 Oral Solid Dosage Pharmaceutical Formulation Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by End User

    6 North America

    • 6.1 North America Oral Solid Dosage Pharmaceutical Formulation by Countries
      • 6.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
      • 6.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Oral Solid Dosage Pharmaceutical Formulation by Product
    • 6.3 North America Oral Solid Dosage Pharmaceutical Formulation by End User

    7 Europe

    • 7.1 Europe Oral Solid Dosage Pharmaceutical Formulation by Countries
      • 7.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
      • 7.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Oral Solid Dosage Pharmaceutical Formulation by Product
    • 7.3 Europe Oral Solid Dosage Pharmaceutical Formulation by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation by Countries
      • 8.1.1 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
      • 8.1.2 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation by Product
    • 8.3 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation by End User

    9 Central & South America

    • 9.1 Central & South America Oral Solid Dosage Pharmaceutical Formulation by Countries
      • 9.1.1 Central & South America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
      • 9.1.2 Central & South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Oral Solid Dosage Pharmaceutical Formulation by Product
    • 9.3 Central & South America Oral Solid Dosage Pharmaceutical Formulation by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by Countries
      • 10.1.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Countries
      • 10.1.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by Product
    • 10.3 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by End User

    11 Company Profiles

    • 11.1 AbbVie
      • 11.1.1 AbbVie Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AbbVie Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.1.5 AbbVie Recent Development
    • 11.2 AstraZeneca
      • 11.2.1 AstraZeneca Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.2.5 AstraZeneca Recent Development
    • 11.3 Bristol-Myers Squibb
      • 11.3.1 Bristol-Myers Squibb Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.3.5 Bristol-Myers Squibb Recent Development
    • 11.4 Eli Lilly and Company
      • 11.4.1 Eli Lilly and Company Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.4.5 Eli Lilly and Company Recent Development
    • 11.5 Gilead Sciences
      • 11.5.1 Gilead Sciences Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.5.5 Gilead Sciences Recent Development
    • 11.6 Merck & Co.
      • 11.6.1 Merck & Co. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Merck & Co. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Merck & Co. Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.6.5 Merck & Co. Recent Development
    • 11.7 Novartis
      • 11.7.1 Novartis Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Novartis Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.7.5 Novartis Recent Development
    • 11.8 Pfizer
      • 11.8.1 Pfizer Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pfizer Oral Solid Dosage Pharmaceutical Formulation Products Offered
      • 11.8.5 Pfizer Recent Development

    12 Future Forecast

    • 12.1 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Regions
      • 12.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Regions 2019-2025
    • 12.2 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Product
      • 12.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Product 2019-2025
      • 12.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Product 2019-2025
    • 12.3 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by End User
    • 12.4 North America Oral Solid Dosage Pharmaceutical Formulation Forecast
    • 12.5 Europe Oral Solid Dosage Pharmaceutical Formulation Forecast
    • 12.6 Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Forecast
    • 12.7 Central & South America Oral Solid Dosage Pharmaceutical Formulation Forecast
    • 12.8 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Oral Solid Dosage Pharmaceutical Formulation Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Oral Solid Dosage Pharmaceutical Formulation market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Solid Dosage Pharmaceutical Formulation market based on company, product type, end user and key regions.

      This report studies the global market size of Oral Solid Dosage Pharmaceutical Formulation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Solid Dosage Pharmaceutical Formulation in these regions.
      This research report categorizes the global Oral Solid Dosage Pharmaceutical Formulation market by top players/brands, region, type and end user. This report also studies the global Oral Solid Dosage Pharmaceutical Formulation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      AbbVie
      AstraZeneca
      Bristol-Myers Squibb
      Eli Lilly and Company
      Gilead Sciences
      Merck & Co.
      Novartis
      Pfizer

      Market size by Product
      Capsules
      Tablets
      Others
      Market size by End User
      Hospitals
      Drugstores
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Oral Solid Dosage Pharmaceutical Formulation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Oral Solid Dosage Pharmaceutical Formulation market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Oral Solid Dosage Pharmaceutical Formulation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Oral Solid Dosage Pharmaceutical Formulation submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Oral Solid Dosage Pharmaceutical Formulation are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Solid Dosage Pharmaceutical Formulation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now